Shandong Wohua Pharmaceutical Co Ltd (002107) - Total Liabilities
Based on the latest financial reports, Shandong Wohua Pharmaceutical Co Ltd (002107) has total liabilities worth CN¥251.47 Million CNY (≈ $36.80 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Shandong Wohua Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Shandong Wohua Pharmaceutical Co Ltd - Total Liabilities Trend (2003–2025)
This chart illustrates how Shandong Wohua Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Shandong Wohua Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Shandong Wohua Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shandong Wohua Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Olvi Oyj A
HE:OLVAS
|
Finland | €267.26 Million |
|
Ridgepost Capital, Inc
NYSE:RPC
|
USA | $506.42 Million |
|
Fleetpartners Group Ltd
AU:FPR
|
Australia | AU$2.11 Billion |
|
Youyou Foods Co Ltd
SHG:603697
|
China | CN¥729.54 Million |
|
RIDLEY CORP. LTD
F:RI6
|
Germany | €276.44 Million |
|
Mensch und Maschine Software SE
F:MUM
|
Germany | €116.41 Million |
|
Ooh!Media Ltd
AU:OML
|
Australia | AU$1.17 Billion |
|
SLR Investment Corp
NASDAQ:SLRC
|
USA | $1.58 Billion |
Liability Composition Analysis (2003–2025)
This chart breaks down Shandong Wohua Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 002107 asset base.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Wohua Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
The table below shows the annual total liabilities of Shandong Wohua Pharmaceutical Co Ltd from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥244.73 Million ≈ $35.81 Million |
-6.87% |
| 2024-12-31 | CN¥262.80 Million ≈ $38.46 Million |
-15.56% |
| 2023-12-31 | CN¥311.23 Million ≈ $45.54 Million |
+0.33% |
| 2022-12-31 | CN¥310.20 Million ≈ $45.39 Million |
+33.81% |
| 2021-12-31 | CN¥231.83 Million ≈ $33.92 Million |
-48.72% |
| 2020-12-31 | CN¥452.08 Million ≈ $66.15 Million |
+94.13% |
| 2019-12-31 | CN¥232.87 Million ≈ $34.08 Million |
+2.77% |
| 2018-12-31 | CN¥226.60 Million ≈ $33.16 Million |
+13.46% |
| 2017-12-31 | CN¥199.71 Million ≈ $29.22 Million |
+50.17% |
| 2016-12-31 | CN¥132.99 Million ≈ $19.46 Million |
+9.94% |
| 2015-12-31 | CN¥120.97 Million ≈ $17.70 Million |
+227.89% |
| 2014-12-31 | CN¥36.89 Million ≈ $5.40 Million |
-7.79% |
| 2013-12-31 | CN¥40.01 Million ≈ $5.85 Million |
-18.81% |
| 2012-12-31 | CN¥49.28 Million ≈ $7.21 Million |
+35.86% |
| 2011-12-31 | CN¥36.28 Million ≈ $5.31 Million |
-20.26% |
| 2010-12-31 | CN¥45.49 Million ≈ $6.66 Million |
-46.73% |
| 2009-12-31 | CN¥85.41 Million ≈ $12.50 Million |
+15.06% |
| 2008-12-31 | CN¥74.23 Million ≈ $10.86 Million |
-32.71% |
| 2007-12-31 | CN¥110.32 Million ≈ $16.14 Million |
+16.81% |
| 2006-12-31 | CN¥94.44 Million ≈ $13.82 Million |
+12.59% |
| 2005-12-31 | CN¥83.88 Million ≈ $12.27 Million |
+19.33% |
| 2004-12-31 | CN¥70.30 Million ≈ $10.29 Million |
-15.59% |
| 2003-12-31 | CN¥83.28 Million ≈ $12.19 Million |
-- |
About Shandong Wohua Pharmaceutical Co Ltd
Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu t… Read more